News

Sleep problems may increase risk for prostate cancer

Men who reported sleep problems, including difficulty falling asleep and staying asleep, had up to a twofold increased risk for prostate cancer, according to recently published data.

Prostate cancer comorbidities increase other-cause death risk for men

Prostate cancer comorbidities increase other-cause death risk for men

For older men with nonmetastatic prostate cancer, comorbidities increase risk of other-cause death mortality.

Bladder cancer could recur despite bladder removal

Additional therapy may be needed for patients with advanced bladder cancers that are surgically removed. A five-year, international study validated the use of a marker panel to predict which patients are more likely to have a recurrence of cancer after bladder removal.

Statin use may reduce deaths from prostate cancer

Men with prostate cancer who used statin drugs prior to diagnosis had a decreased risk of prostate-cancer-specific mortality.

Thoracic endografts successfully remove tumors invading the aorta

Placing a stent within the aorta facilitated the subsequent removal of a tumor in the aorta and eliminated the need for heart-lung bypass for research patients.

DDW: Full-spectrum preferred over forward-viewing colonoscopy

DDW: Full-spectrum preferred over forward-viewing colonoscopy

Increased polyp and adenoma detection rates are associated with use of full-spectrum endoscopy colonoscope.

ASCO: Midlife fitness may protect against lung cancer

ASCO: Midlife fitness may protect against lung cancer

High fitness has been linked to reductions in risk of developing and dying from lung, colorectal cancer.

New prostate cancer test improve risk assessment

A new tool helps identify men who are best suited for active surveillance of prostate cancer, predicting which are more likely to harbor an aggressive form of the disease.

Time to tumor growth best predicts survival in colorectal cancer

Time to tumor growth proved to be the best metric for predicting overall survival in persons with metastatic colorectal cancer on bevacizumab.

ASCO: Combo Antibody Therapy Effective for Melanoma

ASCO: Combo Antibody Therapy Effective for Melanoma

Findings from a phase I study of concurrent ipilimumab and nivolumab for advanced melanoma

Conference Coverage

Rigosertib well tolerated in patients with advanced solid tumors

Orally administered rigosertib was found to be well-tolerated in patients with advanced solid tumors in a phase 1 trial. Rigosertib is a dual kinase inhibitor, and this trial is the first to study its orally administered form in solid tumors.

Quantifying heterogeneity in breast cancer

Later-stage breast cancers tend to have more mutations and are more heterogeneous than early-stage cancers. Now, new findings demonstrate that heterogeneity is prevalent even within legions of DCIS.

New combination of two existing drugs shows promise for resistant lung cancer

A new chemotherapy regimen appears to produce minimal side effects in patients with lung cancer that has not responded to previous therapy, paving the way for additional research to determine if the new regimen also helps shrink tumors.

Biomarker may help identify neuroblastomas vulnerable to a novel class of drugs

An irregularity within many neuroblastoma cells may indicate whether a neuroblastoma tumor is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors.

Gene variations that predict chemotherapy side effects identified

Seemingly benign differences in genetic code from one person to the next could influence who develops side effects to chemotherapy. A new study identified gene variations that can predispose people to chemotherapy-induced peripheral neuropathy.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs